AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2013
Sep 5, 2013
34301_dirs_2013-09-05_ad283978-7b19-43a8-8664-5b3b48888bf9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-09-03
Reporting Person: RICKEY DAVID (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-03 | Common Stock | P | 2000 | $2.14 | Acquired | 110559 | Indirect |
| 2013-09-03 | Common Stock | P | 400 | $2.13 | Acquired | 168501 | Indirect |
| 2013-09-03 | Common Stock | P | 4600 | $2.14 | Acquired | 173101 | Indirect |
| 2013-09-04 | Common Stock | M | 11875 | $2.20 | Acquired | 184976 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-04 | Non-Qualified Stock Option (Right to Buy) | $2.20 | M | 11875 | Acquired | 2022-01-01 | Common Stock (11875) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 34909 | Indirect |
| Restricted Stock Award (Common Stock) | 6100 | Direct |
Footnotes
F1: These securities are owned by the Dave Rickey and Daughters Foundation.
F2: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26